|
|
News Breaks | | | | February 26, 2013 | | 08:09 EDT |  | NEPT | Neptune Technologies obtains third U.S. patent on phospholipid compositions
Neptune Technologies & Bioressources announces that the U.S. Patent & Trademark has granted to Neptune a new continuation patent, U.S. Patent 8,383,675. This new patent claims the benefit of prior Neptune U.S. Patent Nos. 8,030,348 and 8,278,351. The '675 Patent contains a single claim directed to a capsule comprising an Antarctic krill oil extract comprising a phospholipid suitable for human consumption. This claim covers most, if not all, krill oil products presently sold in the U.S. market, as well as the pharmaceutical concentrates of Neptune's subsidiaries Acasti Pharma and NeuroBioPharm. Henri Harland, president and CEO of Neptune, commented; "This is not 'just another patent for Neptune.' It is part of Neptune's IP strategy, and it reinforces Neptune's continual effort to build its patent portfolio and defend its rights. Neptune's recent filing of a complaint with the United States International Trade Commission, as well as the issuance of this third composition patent in the United States, are part of Neptune's well thought and ongoing IP action plan." | |
|
News For NEPT From The Last 14 Days Check below for free stories on NEPT the last two weeks. |
|
|
| May 15, 2013 | | 08:44 EDT | | NEPT | Neptune responds to Aker's attempts to deflect attention from patent dispute
Neptune Technologies & Bioressources announces that the United States Patent and Trademark Office recently issued a NON-FINAL Action Closing Prosecution in a re-examination of Neptune's Patent No. 8,030,348. Aker BioMarine, in yet another clear attempt to shift focus from its ongoing infringement of multiple Neptune patents, issued a press release addressing the re-examination. However Aker neglected to disclose that the USPTO's decision to reject Neptune's claims regarding composition of matter was only one procedural step in the long process of re-examination. Neptune will have the opportunity to submit additional arguments stating its position before the USPTO renders a final decision. | | | 08:20 EDT | | NEPT | Class action against Neptune Technologies dismissed
Neptune Technologies & Bioressources announces that the previously announced class action lawsuit filed against Neptune and certain of its officers on December 19, 2012 by Robbins Geller Rudman & Dowd LLP in the United States District Court for the Southern District of New York was voluntarily dismissed by the plaintiffs, without prejudice. No payment was made by any of the defendants in connection with the dismissal. | |
|
|
|
|
|
|
